TrivarX (ASX:TRI) 3-Year Book Growth Rate : -50.40% (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is TrivarX 3-Year Book Growth Rate?

TrivarX's Book Value per Share for the quarter that ended in Dec. 2023 was A$0.03.

During the past 12 months, TrivarX's average Book Value per Share Growth Rate was -44.40% per year. During the past 3 years, the average Book Value per Share Growth Rate was -50.40% per year. During the past 5 years, the average Book Value per Share Growth Rate was -53.70% per year. During the past 10 years, the average Book Value per Share Growth Rate was -33.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of TrivarX was 1.60% per year. The lowest was -57.40% per year. And the median was -28.70% per year.

Competitive Comparison of TrivarX's 3-Year Book Growth Rate

For the Health Information Services subindustry, TrivarX's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

TrivarX's 3-Year Book Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, TrivarX's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where TrivarX's 3-Year Book Growth Rate falls into.

TrivarX 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

TrivarX (ASX:TRI) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.

TrivarX 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of TrivarX's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

TrivarX (ASX:TRI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » TrivarX Ltd (ASX:TRI) » Definitions » 3-Year Book Growth Rate

Comparable Companies

Traded in Other Exchanges

MDBIF:USA

Address

647 Beaufort Street, Mount Lawley, WA, AUS, 6050

Website

https://www.medibio.com.au

TrivarX Ltd Formerly Medibio Ltd is a medical technology company. The principal activity of the company is conducting clinical research, product development, and early-stage commercialization of mental health technology using objective biomarkers to assist in the screening, diagnosing monitoring, and management of depression and other mental health conditions. It serves both consumer and healthcare provider markets. In addition, the company offers various psychological services to customers in Australia. The company operates in two geographical markets; Australia and the United States. The company has one operating segment, being the research, development, and commercialization of its Software as a Service product.